These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8611095)

  • 1. Multimodality treatment of hepatocellular carcinoma in a hepatobiliary specialty center.
    Marcos-Alvarez A; Jenkins RL; Washburn WK; Lewis WD; Stuart KE; Gordon FD; Kane RA; Clouse ME
    Arch Surg; 1996 Mar; 131(3):292-8. PubMed ID: 8611095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment modalities in patients with hepatocellular carcinoma: a retrospective series in a single institution in Mexico].
    Meza-Junco J; Montaño-Loza A; Candelaria M
    Gastroenterol Hepatol; 2004 Jan; 27(1):11-7. PubMed ID: 14718103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters.
    Roayaie S; Frischer JS; Emre SH; Fishbein TM; Sheiner PA; Sung M; Miller CM; Schwartz ME
    Ann Surg; 2002 Apr; 235(4):533-9. PubMed ID: 11923610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of tumor stage and initial treatment modality in patients with primary hepatocellular carcinoma.
    Xiang X; Zhong JH; Wang YY; You XM; Ma L; Xiang BD; Li LQ
    Clin Transl Oncol; 2017 Jul; 19(7):891-897. PubMed ID: 28160206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma associated with tumor thrombosis in the portal vein: the effects of different treatments.
    Fan J; Wu ZQ; Zhou J; Qiu SJ; Shi YH; Chen RX; Tang ZY
    Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):513-9. PubMed ID: 14627511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma.
    Zhang DZ; Wei XD; Wang XP
    World J Gastroenterol; 2015 Apr; 21(15):4635-43. PubMed ID: 25914473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
    World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort.
    Yoon HM; Kim JH; Kim EJ; Gwon DI; Ko GY; Ko HK
    J Vasc Interv Radiol; 2013 Nov; 24(11):1639-46. PubMed ID: 23962438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodality management of hepatocellular carcinoma larger than 10 cm.
    Mok KT; Wang BW; Lo GH; Liang HL; Liu SI; Chou NH; Tsai CC; Chen IS; Yeh MH; Chen YC
    J Am Coll Surg; 2003 Nov; 197(5):730-8. PubMed ID: 14585406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort study.
    Xue T; Le F; Chen R; Xie X; Zhang L; Ge N; Chen Y; Wang Y; Zhang B; Ye S; Ren Z
    Med Oncol; 2015 Mar; 32(3):64. PubMed ID: 25682389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Liver resection in hepatocellular carcinoma].
    Lauchart W; Sessler MJ; Viebahn R; Naruhn M; Huppert PE; Becker HD
    Zentralbl Chir; 1994; 119(11):764-71. PubMed ID: 7531376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-disciplinary Concurrent Management of Recurrent Hepatocellular Therapy is Superior to Sequential Therapy.
    Fields TD; Philips P; Scoggins CR; Tatum C; Kelly L; McMasters KM; Martin RCG
    World J Surg; 2017 May; 41(5):1331-1339. PubMed ID: 27905019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of Experience.
    Zhang Y; Huang G; Wang Y; Liang L; Peng B; Fan W; Yang J; Huang Y; Yao W; Li J
    Oncologist; 2016 Dec; 21(12):1442-1449. PubMed ID: 27486202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic resection for hepatocellular carcinoma in diameter of > or = 10 cm.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):518-23. PubMed ID: 11995486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved survival with resection after transcatheter arterial chemoembolization (TACE) for unresectable hepatocellular carcinoma.
    Fan J; Tang ZY; Yu YQ; Wu ZQ; Ma ZC; Zhou XD; Zhou J; Qiu SJ; Lu JZ
    Dig Surg; 1998; 15(6):674-8. PubMed ID: 9845635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage surgery following downstaging of unresectable hepatocellular carcinoma.
    Lau WY; Ho SK; Yu SC; Lai EC; Liew CT; Leung TW
    Ann Surg; 2004 Aug; 240(2):299-305. PubMed ID: 15273555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.
    Ye JZ; Zhang YQ; Ye HH; Bai T; Ma L; Xiang BD; Li LQ
    World J Gastroenterol; 2014 Dec; 20(45):17141-7. PubMed ID: 25493028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
    Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
    Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.